We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

93 hedge funds and large institutions have $193M invested in Rigel Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $85.4M → $193M (+$107M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

29% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 24

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

8.47% more ownership

Funds ownership: 59.18% → 67.65% (+8.5%)

2% more funds holding

Funds holding: 91 → 93 (+2)

61% less call options, than puts

Call options by funds: $2.83M | Put options by funds: $7.22M

Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
21
Increased
31
Reduced
24
Closed
18
Calls
$2.83M
Puts
$7.22M
Net Calls
-$4.39M
Net Calls Change
-$4.99M

Top Buyers

1
Invesco
Invesco
Georgia
+$12.1M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$5.19M
3
CM
CM Management
Florida
+$3.41M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$1.44M
5
N
Nuveen
North Carolina
+$1.35M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.51M
2
SCM
Soleus Capital Management
Connecticut
-$1.28M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.12M
4
AC
Armistice Capital
New York
-$1.03M
5
Jane Street
Jane Street
New York
-$944K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$737K -$164K -13,976 -23%
Squarepoint
27
Squarepoint
New York
$732K -$419K -35,653 -44%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$627K +$51.7K +4,399 +13%
AllianceBernstein
29
AllianceBernstein
Tennessee
$509K – – –
State of Wisconsin Investment Board
30
State of Wisconsin Investment Board
Wisconsin
$467K +$339K +28,860 New
Bank of America
31
Bank of America
North Carolina
$463K +$138K +11,741 +69%
Barclays
32
Barclays
United Kingdom
$442K +$197K +16,772 +159%
JP Morgan Chase
33
JP Morgan Chase
New York
$425K +$95.7K +8,140 +45%
Man Group
34
Man Group
United Kingdom
$414K +$1.75K +149 +0.6%
Jane Street
35
Jane Street
New York
$414K -$944K -80,271 -76%
SO
36
STRS Ohio
Ohio
$398K +$81.1K +6,900 +39%
CSS
37
Cubist Systematic Strategies
Connecticut
$393K +$130K +11,064 +84%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$383K -$15.8K -1,342 -5%
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$340K +$228K +19,391 +1,199%
NSEDCP
40
NJ State Employees Deferred Compensation Plan
New Jersey
$324K – – –
Lazard Asset Management
41
Lazard Asset Management
New York
$323K +$235K +20,012 New
PP
42
PDT Partners
New York
$322K +$234K +19,914 New
HIM
43
Hillsdale Investment Management
Ontario, Canada
$301K +$219K +18,600 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$252K -$22.3K -1,897 -11%
JF
45
Jump Financial
Illinois
$247K +$180K +15,285 New
EFMC
46
Empire Financial Management Company
New York
$231K +$168K +14,250 New
Citigroup
47
Citigroup
New York
$216K +$107K +9,107 +214%
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$201K +$13.1K +1,110 +10%
Franklin Resources
49
Franklin Resources
California
$193K +$150K +12,766 New
CWM
50
Connecticut Wealth Management
Connecticut
$186K – – –
1
2
3 4 5

RIGL Hedge Fund Activity: Q3 2024 in Review

93 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2024, worth a combined $193M — up 126% from $85.4M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RIGL positions and 18 closed out — a net gain of 3 holders — while 31 added to existing stakes and 24 trimmed.

The largest buyer was Invesco, adding an estimated $12.1M. The largest seller was Acadian Asset Management, cutting an estimated $1.51M.

  • 93 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2024, up from 91 in Q2 2024.
  • Funds reported $193M of Rigel Pharmaceuticals stock for Q3 2024, up 126% quarter-over-quarter.
  • 21 funds opened new Rigel Pharmaceuticals positions in Q3 2024 and 18 closed out, a net change of +3 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2024 was Invesco, an estimated $12.1M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2024 was Acadian Asset Management, an estimated $1.51M sold.

Based on aggregated 13F filings for Q3 2024.